Medication info
Cetrara Tablet

Cetrara Tablet

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›37.5mg / 1 tabletAcetaminophen›325mg / 1 tablet
Manufacturer / importer
Cielpharm Co., Ltd.
Appearance
Light yellow rectangular film-coated tablet
Packaging
30 tablets, 300 tablets
Approval status
Active

MFDS item code 201600427 · Approved 2016.01.25 · Insurance code 622600230

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Elderly patients Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to elderly patients aged 75 years or older, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance below 10ml/min). Since tramadol is removed very slowly during hemodialysis and filtration, this drug does not need to be readministered after dialysis to maintain analgesic effects. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: Adjust the dose according to the patient's level of pain and response to treatment. An initial dose of 2 tablets is recommended; thereafter, allow an interval of at least 6 hours between doses, and do not exceed 8 tablets per day. Administer the lowest effective dose for the shortest possible duration. Do not administer this drug for longer than necessary. If long-term administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this drug should be continued.

Ingredients

Manufacturer
Cielpharm Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate acute pain
  • moderate chronic pain
  • severe acute pain
  • severe chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Elderly patients Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to elderly patients aged 75 years or older, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance below 10ml/min). Since tramadol is removed very slowly during hemodialysis and filtration, this drug does not need to be readministered after dialysis to maintain analgesic effects. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: Adjust the dose according to the patient's level of pain and response to treatment. An initial dose of 2 tablets is recommended; thereafter, allow an interval of at least 6 hours between doses, and do not exceed 8 tablets per day. Administer the lowest effective dose for the shortest possible duration. Do not administer this drug for longer than necessary. If long-term administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this drug should be continued.

Precautions

This medication may cause liver damage, so those who regularly consume more than three drinks a day should consult a doctor or pharmacist. This medication can rarely cause serious skin reactions; if skin rash or hypersensitivity occurs, discontinue use immediately. The ingredients in this medication may increase the risk of seizures, so patients with a history of seizures or seizure risk factors should use it with caution. Severe respiratory depression that can be life-threatening may occur in patients with significant respiratory diseases; administration should occur in a medically equipped setting. Taking this medication with alcohol or central nervous system depressants can lead to severe sedation or respiratory depression, so this should be avoided or done with caution. Patients with increased intracranial pressure or head injury may experience exacerbation of symptoms due to the respiratory depression effect of this medication; therefore, it should be administered cautiously. This medication may cause psychological and physical dependence, so long-term use should be closely monitored for the development of dependence. Patients with impaired liver function should consult a doctor before taking this medication and should ensure that the daily dosage does not exceed 4,000mg. Patients with certain genotypes may metabolize this medication rapidly, increasing the risk of respiratory depression, so dose adjustments and symptom monitoring are necessary. This medication should not be used in children under 12 years old or adolescents under 18 years old who have undergone tonsillectomy or adenoidectomy. This medication can cause sleep apnea or hypoxemia, so symptoms need to be continuously evaluated and dosages adjusted as necessary. Elderly patients or those at risk for hyponatremia should be closely monitored for the occurrence of hyponatremia. Patients who have hypersensitivity to the ingredients of this medication, those taking certain medications, patients with severe respiratory depression, and those with head injuries should not be administered this medication. Patients taking narcotic analgesics or central nervous system depressants, those with liver or kidney disorders, and those who consume alcohol should use this medication with caution and follow medical advice. Drowsiness or dizziness may occur while taking this medication, so caution should be exercised when driving or operating hazardous machinery. In cases of overdose, serious respiratory depression, seizures, or liver failure may occur, so dosing must be strictly adhered to. If symptoms such as seizures, allergic reactions, or respiratory difficulties appear while taking this medication, inform medical personnel immediately and seek treatment.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, death, appetite loss, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rashes, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, irritability, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory loss, tremors, sensory abnormalities, attention deficit, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, pupillary constriction, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, elevated liver enzymes, generalized pruritus, diaphoresis, urination disorders, erectile dysfunction, weakness, chest pain, emotional abnormality, chills, chest discomfort, fatigue, withdrawal syndrome from medication, thirst, irritability, heat sensation, weight loss, increased blood creatinine, anaphylactic reaction, influence on emotional instability, delirium, suicidal thoughts, muscle rigidity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, hematological disorders, hyponatremia, fixed rashes, weakness, fever, edema, rigidity, syncope, congestive heart failure, vertigo, confusion, tension hyperreactivity, exacerbation of migraine, involuntary muscle contractions, dyspnea, asthma, exercise-induced dyspnea, cough, bronchitis, urinary retention, increased urination, abnormal kidney function tests, oliguria, rashes, increased sweating, urticaria, dysphagia, lingual edema, drooling, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic intestinal obstruction, hiccups, cholecystitis, drowsiness, insomnia, appetite loss, anxiety, depression, irritability, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased erythrocytes, decreased leukocytes, increased leukocytes, thrombocytopenia, palpitations, arrhythmias, exacerbation of hypertension, aortic stenosis, bleeding, elevated cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of bile duct cancer, sensation of foreign body in the eye, progression of liver cancer, liver dysfunction, nausea, constipation, vomiting, dizziness, confusion, delirium, multiple organ failure, intentional overdose, belching, chest discomfort, anxiety, sweating, rigidity, pain, upper respiratory tract syndrome, salivation, agitation, hyperactivity, panic attacks, severe anxiety, tinnitus, abnormal central nervous system reactions, urticaria, bronchospasm, toxic skin necrosis, opioid-induced hyperalgesia, withdrawal symptoms, symptoms of acute or chronic adrenal insufficiency, myocardial infarction, QT prolongation, liver failure, renal tubular necrosis, coagulopathy, abdominal discomfort, fatigue, pallor, hyperhidrosis, respiratory arrest

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air exposure, and it is best kept at room temperature between 1 and 30 degrees. Proper storage will help maintain the medication's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

Light yellow rectangular film-coated tablet

Package unit

30 tablets, 300 tablets

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.